Literature DB >> 22155308

Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.

Krisztina M Papp-Wallace1, Christopher R Bethel, Thomas D Gootz, Wenchi Shang, Justin Stroh, William Lau, Dale McLeod, Loren Price, Anthony Marfat, Anne Distler, Sarah M Drawz, Hansong Chen, Emily Harry, Micheal Nottingham, Paul R Carey, John D Buynak, Robert A Bonomo.   

Abstract

β-Lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam) contribute significantly to the longevity of the β-lactam antibiotics used to treat serious infections. In the quest to design more potent compounds and to understand the mechanism of action of known inhibitors, 6β-(hydroxymethyl)penicillanic acid sulfone (6β-HM-sulfone) was tested against isolates expressing the class A TEM-1 β-lactamase and a clinically important variant of the AmpC cephalosporinase of Pseudomonas aeruginosa, PDC-3. The addition of the 6β-HM-sulfone inhibitor to ampicillin was highly effective. 6β-HM-sulfone inhibited TEM-1 with an IC(50) of 12 ± 2 nM and PDC-3 with an IC(50) of 180 ± 36 nM, and displayed lower partition ratios than commercial inhibitors, with partition ratios (k(cat)/k(inact)) equal to 174 for TEM-1 and 4 for PDC-3. Measured for 20 h, 6β-HM-sulfone demonstrated rapid, first-order inactivation kinetics with the extent of inactivation being related to the concentration of inhibitor for both TEM-1 and PDC-3. Using mass spectrometry to gain insight into the intermediates of inactivation of this inhibitor, 6β-HM-sulfone was found to form a major adduct of +247 ± 5 Da with TEM-1 and +245 ± 5 Da with PDC-3, suggesting that the covalently bound, hydrolytically stabilized acyl-enzyme has lost a molecule of water (HOH). Minor adducts of +88 ± 5 Da with TEM-1 and +85 ± 5 Da with PDC-3 revealed that fragmentation of the covalent adduct can result but appeared to occur slowly with both enzymes. 6β-HM-sulfone is an effective and versatile β-lactamase inhibitor of representative class A and C enzymes. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155308      PMCID: PMC3319978          DOI: 10.1016/j.bcp.2011.11.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

1.  The synthesis and evaluation of 6-alkylidene-2'beta-substituted penam sulfones as beta-lactamase inhibitors.

Authors:  J D Buynak; A S Rao; V R Doppalapudi; G Adam; P J Petersen; S D Nidamarthy
Journal:  Bioorg Med Chem Lett       Date:  1999-07-19       Impact factor: 2.823

Review 2.  The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.

Authors:  John D Buynak
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

3.  Penicillin and other antibiotics.

Authors:  H FLOREy
Journal:  Adv Sci       Date:  1948-01       Impact factor: 16.806

Review 4.  Updated functional classification of beta-lactamases.

Authors:  Karen Bush; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

5.  Biochemical characteristics of extended broad spectrum beta-lactamases.

Authors:  K Bush; S B Singer
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.

Authors:  Sarah M Drawz; Magdalena Taracila; Emilia Caselli; Fabio Prati; Robert A Bonomo
Journal:  Protein Sci       Date:  2011-05-03       Impact factor: 6.725

8.  Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase.

Authors:  German Bou; Elena Santillana; Anjaneyulu Sheri; Alejandro Beceiro; Jared M Sampson; Matthew Kalp; Christopher R Bethel; Anne M Distler; Sarah M Drawz; Sundar Ram Reddy Pagadala; Focco van den Akker; Robert A Bonomo; Antonio Romero; John D Buynak
Journal:  J Am Chem Soc       Date:  2010-09-29       Impact factor: 15.419

9.  Inactivation of the RTEM beta-lactamase from Escherichia coli. Interaction of penam sulfones with enzyme.

Authors:  J Fisher; R L Charnas; S M Bradley; J R Knowles
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

10.  Penicillin-derived inhibitors that simultaneously target both metallo- and serine-beta-lactamases.

Authors:  John D Buynak; Hansong Chen; Lakshminaryana Vogeti; Venkat Rao Gadhachanda; Christine A Buchanan; Timothy Palzkill; Robert W Shaw; James Spencer; Timothy R Walsh
Journal:  Bioorg Med Chem Lett       Date:  2004-03-08       Impact factor: 2.823

View more
  8 in total

1.  A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems.

Authors:  Krisztina M Papp-Wallace; Susana Mallo; Christopher R Bethel; Magdalena A Taracila; Andrea M Hujer; Ana Fernández; Julian A Gatta; Kerri M Smith; Yan Xu; Malcolm G P Page; Eric Desarbre; Germán Bou; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2013-11-13       Impact factor: 5.790

Review 2.  One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams.

Authors:  Dustin T King; Solmaz Sobhanifar; Natalie C J Strynadka
Journal:  Protein Sci       Date:  2016-03-09       Impact factor: 6.725

Review 3.  New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.

Authors:  Sarah M Drawz; Krisztina M Papp-Wallace; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

4.  Penam sulfones and β-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.

Authors:  Elizabeth A Rodkey; Marisa L Winkler; Christopher R Bethel; Sundar Ram Reddy Pagadala; John D Buynak; Robert A Bonomo; Focco van den Akker
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

5.  Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone.

Authors:  Tao Che; Elizabeth A Rodkey; Christopher R Bethel; Sivaprakash Shanmugam; Zhe Ding; Marianne Pusztai-Carey; Michael Nottingham; Weirui Chai; John D Buynak; Robert A Bonomo; Focco van den Akker; Paul R Carey
Journal:  Biochemistry       Date:  2015-01-08       Impact factor: 3.162

6.  Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex.

Authors:  Constain H Salamanca; Cristhian J Yarce; Yony Roman; Andrés F Davalos; Gustavo R Rivera
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-10

7.  Search for non-lactam inhibitors of mtb β-lactamase led to its open shape in apo state: new concept for antibiotic design.

Authors:  Amin Sagar; Nazia Haleem; Yaawar Mir Bashir
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

Review 8.  Exploring Additional Dimensions of Complexity in Inhibitor Design for Serine β-Lactamases: Mechanistic and Intra- and Inter-molecular Chemistry Approaches.

Authors:  Focco van den Akker; Robert A Bonomo
Journal:  Front Microbiol       Date:  2018-04-05       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.